Cyrus Chargari

Papers

Total Citations

280

H-Index

About

Cyrus Chargari is a leading figure in gynecologic and urologic oncology, whose research bridges surgical innovation and radiotherapy. His seminal work includes a landmark systematic review on fertility-sparing surgery for cervical cancer, which has garnered over 270 citations and shaped clinical guidelines for young patients seeking to preserve reproductive potential. Chargari’s contributions extend to comparative effectiveness research, as demonstrated by his cost-utility analysis of robot-assisted surgery versus robotic stereotactic body radiotherapy for prostate cancer—a study that addresses the economic and clinical trade-offs in treating France’s most common male malignancy. By quantifying the impacts of these advanced technologies, he provides critical evidence for personalized treatment decisions. Chargari’s research is distinguished by its focus on optimizing oncological outcomes while minimizing toxicity and costs, reflecting a patient-centered approach. His work not only advances surgical and radiotherapeutic techniques but also informs health policy, making him a key voice in the integration of robotics into cancer care. With a career dedicated to improving survival and quality of life, Chargari continues to influence both clinical practice and research directions in oncology.